Bio-Rad Laboratories

July 02, 2020

Covid-19 divides the biggest medtechs

Success or failure on the stock markets this year depended almost entirely on whether a company’s devices could be used to treat coronavirus patients.

June 18, 2020

The FDA gets aggressive with Covid-19 antibody tests

Chembio’s antibody test is the first to have its authorisation revoked. It might not be the last.

May 04, 2020

Roche takes on Abbott in Covid-19 antibody testing

Robust specificity data mark Roche’s serological test out as a major competitor.

January 09, 2017

A quiet year for mid-size medtech

January 27, 2015

FDA device approvals get faster still

July 24, 2013

Bio-Rad Laboratories

Covid-19 divides the biggest medtechs

The FDA gets aggressive with Covid-19 antibody tests

Roche takes on Abbott in Covid-19 antibody testing

A quiet year for mid-size medtech

FDA device approvals get faster still

EP Vantage interview – Ariana’s algorithms could deliver bespoke cancer therapy

Latest Reports

Biopharma and Medtech Half-Year Review 2021

Evaluate Vantage Biopharma and Venture Capital: A Deep Dive

Editor's Picks

Esmo 2021 – Mirati bids to be belle of the ball

World Lung 2021 preview – China challenges and tremelimumab rises

Roche U-turns and Adaptimmune wins

Tecentriq pullout dominates the latest PD-(L)1 moves

Another gene therapy safety scare hits